Regulus Therapeutics (RGLS) – FDA
-
Regulus Therapeutics (RGLS) Reports Positive Topline Data from the Second Cohort in Phase 1b Trial of RGLS8429
-
Regulus Therapeutics (RGLS) Announces Positive Topline Data from First Cohort of Patients in its Phase 1b MAD Clinical Trial of RGLS8429 for Treatment of ADPKD
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to RGLS Stock Lookup